90:

Yulong Li1, Jinyun Dong2, Jiang-Jiang Qin2

  • 1Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, China; School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China.

概括

热冲击蛋白90 (HSP90) 抑制剂在治疗癌症等疾病方面表现有前途. 本综述总结了最近关于HSP90抑制剂结构,设计和活动的研究,包括天然和合成化合物.